Piperazine sulfonamides as DPP-IV inhibitors: Synthesis, induced-fit docking and in vitro biological evaluation
, y
03 abr 2021
Acerca de este artículo
Publicado en línea: 03 abr 2021
Páginas: 631 - 643
Aceptado: 20 oct 2020
DOI: https://doi.org/10.2478/acph-2021-0034
Palabras clave
© 2021 Reema Abu Khalaf et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Khalaf, Reema Abu
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of JordanAmman, Jordan
Alwarafi, Ebtisam
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of JordanAmman, Jordan
Sabbah, Dima
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of JordanAmman, Jordan